1 Table of Contents
1.1 List of Figures
1.2 List of Tables
2 Thromboembolism Pipeline Analysis
2.1 Disease and Pipeline Overview
2.2 Thromboembolism Pipeline Snapshot
2.3 Thromboembolism Pipeline by Phase
2.4 Thromboembolism Pipeline by Company
2.5 Thromboembolism Pipeline by Mechanism of Action

3 Thromboembolism- Company Wise Pipeline Analysis
Arrowhead Pharmaceuticals, Inc
Bayer AG
China Biologic Products Holdings, Inc.
Daiichi Sankyo Company, Limited
Ionis Pharmaceuticals Inc
Janssen Pharmaceuticals, Inc.
Lee's Pharmaceutical Holdings
Pfizer Inc
Prothix BV
Quercegen Pharmaceuticals LLC
Roche Holding AG
Shandong Taibang Biological Products Co.Ltd.
TeaRx Ltd.
Verseon Corp

4 Thromboembolism R&D Pipeline Snapshots
Drug wise Pipeline Details
Therapeutic Candidate Name
Originator
Co-Developer/ License Partner
Orphan Drug Designation
Development Phase
Mechanism of Action
Current Status
Ongoing Clinical Trial Details

5 Recent Developments in Thromboembolism Pipeline

6 Appendix
6.1 About VPA Research
6.2 Sources and Research Methodology

Figures
Figure 1: Thromboembolism Pipeline by Phase, H2- 2018
Figure 2: Thromboembolism Pipeline by Companies, H2- 2018
Figure 3: Company Wise Pipeline Drug Phases, H2- 2018
Figure 4: Thromboembolism Pipeline by Mechanism of Action, H2- 2018
Figure 5: Mechanism Wise Pipeline Drug Phases, H2- 2018

Tables-
Thromboembolism Pipeline by Phase, H2- 2018
Thromboembolism Pipeline by Companies, H2- 2018
Thromboembolism Pipeline by Mechanism of Action, H2- 2018

Table 1: Arrowhead Pharmaceuticals, Inc Thromboembolism Pipeline Drugs, H2- 2018
Table 2: Bayer AG Thromboembolism Pipeline Drugs, H2- 2018
Table 3: China Biologic Products Holdings, Inc. Thromboembolism Pipeline Drugs, H2- 2018
Table 4: Daiichi Sankyo Company, Limited Thromboembolism Pipeline Drugs, H2- 2018
Table 5: Ionis Pharmaceuticals Inc Thromboembolism Pipeline Drugs, H2- 2018
Table 6: Janssen Pharmaceuticals, Inc. Thromboembolism Pipeline Drugs, H2- 2018
Table 7: Lee's Pharmaceutical Holdings Thromboembolism Pipeline Drugs, H2- 2018
Table 8: Pfizer Inc Thromboembolism Pipeline Drugs, H2- 2018
Table 9: Prothix BV Thromboembolism Pipeline Drugs, H2- 2018
Table 10: Quercegen Pharmaceuticals LLC Thromboembolism Pipeline Drugs, H2- 2018
Table 11: Roche Holding AG Thromboembolism Pipeline Drugs, H2- 2018
Table 12: Shandong Taibang Biological Products Co.Ltd. Thromboembolism Pipeline Drugs, H2- 2018
Table 13: TeaRx Ltd. Thromboembolism Pipeline Drugs, H2- 2018
Table 14: Verseon Corp Thromboembolism Pipeline Drugs, H2- 2018

Companies Mentioned
• Arrowhead Pharmaceuticals, Inc
• Bayer AG
• China Biologic Products Holdings, Inc.
• Daiichi Sankyo Company, Limited
• Ionis Pharmaceuticals Inc
• Janssen Pharmaceuticals, Inc.
• Lee's Pharmaceutical Holdings
• Pfizer Inc
• Prothix BV
• Quercegen Pharmaceuticals LLC
• Roche Holding AG
• Shandong Taibang Biological Products Co.Ltd.
• TeaRx Ltd.
• Verseon Corp